Honeywell 2Q26 beat expectations, with improved delivery on growth and margins; Bernstein raises target price to 264 USD

Overview

This report is Bernstein's review of Honeywell International Inc following its 2Q26 results. The core conclusion is that Honeywell previously needed to prove to the market its ability to deliver on growth and margins, and the 2Q26 performance makes that story more credible. On the revenue side, organic growth was 4%, clearly above consensus expectations of roughly flat; adjusted operating margin was about 19%, broadly in line with expectations; adjusted EPS was 1.95 USD, about 7% above consensus. Management also slightly raised full-year guidance for organic growth, segment margin, and EPS.

Core views

Bernstein maintains a Market-Perform rating on Honeywell, but raises the target price from 243.00 USD to 264.00 USD. The report believes the second-half organic growth guidance of 4%-6% is conservative. Continued mid- to high-single-digit growth in Building Automation, recovery in PAT supported by catalysts and LNG orders, and Industrial Automation benefiting from the divestiture of low-margin businesses and operating leverage could all help the company reach the high end of guidance or even exceed it. If the company sustains the execution quality seen in 2Q26 over the next few quarters, the stock could see some re-rating.

Analysis framework

The report follows three main lines of analysis: first, comparing 2Q26 actual revenue, organic growth, segment profit, and EPS against consensus expectations; second, analyzing the growth and margin path for BA, IA, PAT, and Forge respectively; and finally, revaluing the target price based on updated earnings forecasts, forward P/E multiples, and the value of the Quantinuum stake.

Methodology notes

• Valuation methodssum_of_the_parts_plus_pe

  P/E valuation plus Quantinuum stake value

  Bernstein uses NTM+1 EPS of 11.24 USD, multiplies it by a 20x forward P/E, and additionally includes approximately 39 USD/share of Quantinuum stake value to derive Honeywell's 264 USD target price.

• earnings_reviewactual_vs_consensus

  Actual results versus consensus expectations

  The report compares 2Q26 revenue, organic growth, segment profit, operating margin, and adjusted EPS against VA consensus expectations to assess earnings quality and the degree of outperformance.

• segment_analysisbusiness_unit_bridge

  Segment growth and margin bridge

  The report breaks down the growth drivers, margin improvement drivers, and potential risks across Building Automation, Industrial Automation, Process Automation and Technologies, and Forge.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• HON.US

  Core covered asset

  Strengths

  2Q26 organic growth, EPS, and all segment performances beat expectations; full-year guidance was raised; BA growth is stable, and the path to IA margin improvement is clearer.

  Weaknesses

  The rating remains Market-Perform; near-term project mix in PAT and Johnson Matthey integration may weigh on margins; IA margin delivery still requires further validation.

  Comparison

  Versus consensus expectations, 2Q26 revenue, organic growth, segment profit, and EPS all beat; versus Bernstein's prior view, the report clearly reduces skepticism about delivery on growth and margins.

  Risks

  Downturn in industrial short-cycle demand, delays in LNG projects, slowing IA growth, and organizational drag from the aerospace separation.

• Quantinuum Inc.

  An important component of Honeywell's stake value

  Strengths

  Bernstein includes the value of Honeywell's QNT holdings at about 39 USD/share in HON's valuation, while QNT itself is valued based on 12-month forward revenue and an EV/Forward Sales methodology.

  Weaknesses

  There remains execution uncertainty around the commercialization of quantum computing and revenue conversion.

  Comparison

  Excluding QNT value, the report believes HON's apparent P/E is artificially elevated, and the actual valuation looks more reasonable.

  Risks

  Delays in next-generation quantum computer delivery, engineering and manufacturing issues worse than expected, breakthroughs in competing technology pathways, market size below expectations, or slower-than-expected conversion of the commercial pipeline into revenue.

Key data

• RatingMarket-PerformBernstein maintains the rating unchanged.
• Target Price264.00 USDThe previous target price was 243.00 USD.
• Current Price241.12 USDThe ticker table shows this as of 2026-07-29.
• 2Q26 Organic Growth4.0%Versus VA consensus expectation of 0.2%, a beat of 383 bps.
• 2Q26 Adjusted EPS1.95 USDVersus consensus expectation of 1.82 USD, about 7.4% higher.
• 2Q26 Operating Margin19.0%Versus consensus expectation of 18.9%, slightly above expectations.
• 2026 Organic Growth Guidance3%-4%Previously 2%-3%.
• 2026 Adjusted EPS Guidance8.05-8.35 USDMidpoint is about 8.20 USD, versus a previous midpoint of about 8.10 USD.
• Valuation AssumptionNTM+1 EPS 11.24 USD × 20x P/E + approximately 39 USD/share QNT valueThe 20x multiple is unchanged, and the QNT target price assumption is 94 USD.

Impact & implications

The report's investment implication is constructive but not explicitly bullish. 2Q26 demonstrates improved delivery by Honeywell on both growth and margins, especially as second-half growth guidance may be conservative, and the path to higher IA margins appears more acceptable to the market. If the company continues to deliver results similar to 2Q26, valuation could be re-rated; however, the rating remains Market-Perform, indicating that even after the target price increase, expected returns still do not meet the threshold for Outperform.

Risks

• A major escalation in the Middle East situation or a significant downturn in industrial short-cycle demand could weaken second-half growth.
• If Industrial Automation growth slows, the operating leverage underpinning the 22% margin target could come under risk.
• PAT has a heavier project mix in 2H26, and Johnson Matthey integration brings near-term margin pressure.
• If LNG projects are delayed or weaken, the market may not yet be fully pricing this in.
• The aerospace separation may create organizational drag.
• Uncertainty around Quantinuum's commercialization, technology path, and market size may affect the value of Honeywell's stake.

What to watch

• Whether Honeywell's second-half organic growth reaches the high end of or exceeds the 4%-6% guidance range.
• Whether IA margin can improve from about 17% to around 22% in 4Q26, and the actual contribution after the divestiture of PSS/WWS.
• Whether BA can continue to maintain high-single-digit organic growth and sequential margin improvement.
• The impact of recovering PAT catalyst volumes, LNG order conversion, and Johnson Matthey integration on margins.
• Whether the roughly 15% growth target for Forge software revenue is raised, and whether connected asset growth can translate into higher recurring revenue.
• If subsequent quarters sustain the execution quality of 2Q26, whether the market re-rates HON.